Fig. 3: Perspectives of multi-omics in research of HNSCC immunotherapy.
From: Multi-omics in immunotherapy research for HNSCC: present situation and future perspectives
Future multi-omics has better development potential in five aspects, including the selection and processing of sequencing samples, the integration and analysis of data, the use of emerging technologies, the analysis combined with clinicopathological features, and the use of artificial intelligence. Created with BioRender.com.
